RiceBran Technologies (NASDAQ: RIBT) rose 16.1% to $1.37 in pre-market trading after jumping around 27% on Tuesday. The company is scheduled to report Q1 earnings today. Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) rose 13.7% to $4.57 in pre-market trading. Mind Medicine commenced trading its subordinate voting shares on The Nasdaq Capital Market Tuesday. Sphere 3D Corp. (NASDAQ: ANY) rose 12.6% to $2.43 in pre-market trading after falling over 6% on Tuesday. Tian Ruixiang Holdings Ltd (NASDAQ: TIRX) shares rose 10.3% to $18.07 in pre-market trading. Tian Ruixiang shares climbed over 36% on Tuesday after the company reported its financial results for the fiscal year ended October 31, 2020. Deutsche Bank Aktiengesellschaft (NYSE: DB) rose 7.7% to $13.30 in pre-market trading after reporting upbeat quarterly profit. Aurora Mobile Limited (NASDAQ: JG) rose 7.7% to $3.79 in pre-market trading. Aurora Mobile and Zhengzhou Space-Time Tunnel Information Technology Co. recently announced a partnership. GSX Techedu Inc. (NYSE: GSX) rose 7.7% to $34.44 in pre-market trading. The company recently reported FY20 earnings results. Boyd Gaming Corporation (NYSE: BYD) rose 7.3% to $74.00 in pre-market trading after the company reported better-than-expected Q1 results. Boxlight Corporation (NASDAQ: BOXL) shares rose 7% to $2.61 in pre-market trading after declining around 5% on Tuesday. Tellurian Inc. (NASDAQ: TELL) shares rose 6.5% to $2.30 in pre-market trading. The company’s Tellurian Production Holdings subsidiary last week announced the prepayment of the $17 millionoutstanding balance on its senior secured term loan credit agreement. Atossa Therapeutics, Inc. (NASDAQ: ATOS) rose 5.6% to $2.07 in pre-market trading. Atossa Therapeutics recently filed for shelf of up to 13 million shares of common stock by selling stockholders. Alphabet Inc. (NASDAQ: GOOGL) rose 5.1% to $2,407.00 in pre-market trading after the company reported better-than-expected results for its first quarter and also announced a $50 billion Class C capital stock buyback program. Advanced Micro Devices, Inc. (NASDAQ: AMD) shares rose 4.3% to $88.85 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 sales guidance.
Find out what’s going on in today’s market and bring any questions you have to Benzinga’s PreMarket Prep.
Protalix BioTherapeutics, Inc. (NYSE: PLX) fell 35.9% to $3.74 in pre-market trading. Protalix BioTherapeutics and Chiesi Global Rare Diseases reported a Complete Response Letter for Pegunigalsidase Alfa as a treatment for Fabry disease from the FDA. Benitec Biopharma Inc. (NASDAQ: BNTC) shares fell 22.8% to $4.23 in pre-market trading after the company increased previously announced bought deal offering of common stock to 3.03 million shares priced at $4.25 per share. BioVie Inc. (NASDAQ: BIVI) fell 16.3% to $18.00 in pre-market trading after the company announced it acquired biopharma assets from privately held NeurMedix. Pinterest, Inc. (NYSE: PINS) fell 10.5% to $69.45 in pre-market trading after the company reported Q1 earnings results. Enphase Energy, Inc. (NASDAQ: ENPH) fell 7.4% to $158.40 in pre-market trading after the company issued weak Q2 sales guidance. AzurRx BioPharma, Inc. (NASDAQ: AZRX) fell 6.6% to $0.9622 in pre-market trading after jumping over 15% on Tuesday. Vertex Energy, Inc. (NASDAQ: VTNR) fell 6.2% to $1.36 in pre-market trading after gaining over 4% on Tuesday. Nxt-ID, Inc. (NASDAQ: NXTD) fell 5.7% to $0.9712 in pre-market trading after climbing around 15% on Tuesday. Zomedica Corp. (NYSE: ZOM) fell 5.5% to $1.04 in pre-market trading. Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) fell 4.9% to $14.13 in pre-market trading after the company reported a proposed $125 million public offering of common stock. Amgen Inc. (NASDAQ: AMGN) fell 3.9% to $245.21 in pre-market trading after the company reported worse-than-expected Q1 results. Microsoft Corporation (NASDAQ: MSFT) shares fell 2.2% to $256.36 in pre-market trading after the company reported Q3 earnings results.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.